BioVascular Overview

  • Founded
  • 2005
Founded
  • Status
  • Private
  • Employees
  • 4
Employees
  • Latest Deal Type
  • 2ndary - Private
  • Investors
  • 2

BioVascular General Information

Description

Developer of drugs and devices designed to treat significant unmet medical needs. The company's devices control intimal hyperplasia associated with vascular procedures and control factors associated with cardiovascular morbidity and mortality, develop saratin for either hemodialysis access grafts or peripheral bypass grafting, enabling medical clinics for the treatment and prevention of vascular disease for the reduction of a recently defined cardiovascular risk factor.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Pharmaceuticals
Drug Discovery
Primary Office
  • 12230 El Camino Real
  • Suite 100
  • San Diego, CA 92130
  • United States
+1 (858) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

BioVascular Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Secondary Transaction - Private 0000 Completed Generating Revenue
3. Later Stage VC (Series C) 07-Feb-2008 000.00 0000 000.00 Completed Generating Revenue
2. Early Stage VC (Series B) 01-Nov-2007 $4.09M $8.09M 000.00 Completed Generating Revenue
1. Early Stage VC (Series A) 11-Jul-2005 $4M $4M 0000 Completed Startup
To view BioVascular’s complete valuation and funding history, request access »

BioVascular Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.00
Series B 0,000,000 00.000000 00 00 00 00 00 00.000
Series A 4,000,000 $0.001000 8% $1 $1 1x $1 14.6%
To view BioVascular’s complete cap table history, request access »

BioVascular Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of drugs and devices designed to treat significant unmet medical needs. The company's devices control intimal
Therapeutic Devices
San Diego, CA
4 As of 2020
0000
000000 - 000 0000

0000000

amco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in volu
0000 000000000
San Diego, CA
0000
000 0000-00-00
00000000000 0000

0000000

t aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse ci
0000000000 000000000
Hartford, CT
00 As of 0000
00.000
0.000 0000-00-00
000000&0 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

BioVascular Competitors (18)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Neurana Pharmaceuticals Venture Capital-Backed San Diego, CA 0000 00000000000 0000
0000000 Formerly VC-backed Hartford, CT 00 00.000 000000&0 00.000
0000000 0000000000 Formerly VC-backed Cambridge, MA 000 000.00 000000000 000.00
000000 00000000000 Venture Capital-Backed Carlsbad, CA 0 000.00 00000000000 000.00
0000000 000000 Formerly VC-backed Balma, France 0 00000 000000000 00000
You’re viewing 5 of 18 competitors. Get the full list »

BioVascular Executive Team (4)

Name Title Board Seat Contact Info
John Parrish Ph.D Co-Founder, President, Chief Executive Officer & Board Member
Paul Glidden Ph.D Co-Founder & Board Member
Alison Pilgrim Ph.D Chief Medical Officer & Vice President, Clinical Research & Regulatory Affairs
Christopher Bussineau Ph.D Vice President of Pharmaceutical Operations
To view BioVascular’s complete executive team members history, request access »

BioVascular Board Members (6)

Name Representing Role Since
Arno Hartmann Ph.D Self Board Member 000 0000
Brian Dovey Domain Associates Board Member 000 0000
John Parrish Ph.D BioVascular Co-Founder, President, Chief Executive Officer & Board Member 000 0000
Martin Munchbach Ph.D Self Board Member 000 0000
Paul Glidden Ph.D BioVascular Co-Founder & Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

BioVascular Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BioVascular Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
BB Biotech Asset Manager Minority 000 0000 000000 0
Merck Capital Ventures Corporate Venture Capital Minority 000 0000 000000 0
To view BioVascular’s complete investors history, request access »

BioVascular Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 10-Sep-2007 000000000000000000 Drug Discovery 0000 0000000 00.0
To view BioVascular’s complete acquisitions history, request access »